Skip to main content

Silvia Cabrera Diaz

Institutions of which they are part

Main researcher
Biomedical Research in Gynaecology
Vall Hebron Institut de Recerca

Silvia Cabrera Diaz

Institutions of which they are part

Main researcher
Biomedical Research in Gynaecology
Vall Hebron Institut de Recerca

Projects

ScreenEC, validació d'una eina de triatge no invasiu en càncer d'endometri

IP: Eva Colas Ortega
Collaborators: Vicente Bebia Conesa, Francesc Xavier Serra Marin, Josep Castellví Vives, Silvia Cabrera Diaz, Antonio Gil Moreno, Marta Rebull Santamaria, Ana Luzarraga Aznar, Irene De la Calle Fuentes, Lourdes Elena Salazar Huayna
Funding agency: Generalitat de Catalunya - Departament de Salut
Funding: 99946
Reference: SLT036/24/000059
Duration: 21/12/2024 - 31/12/2026

Desarrollo de CEMARK-Px, un método in vitro para el diagnóstico objetivo y preciso del tipo y grado histológico del cáncer de endometrio en fluido uterino

IP: Eva Colas Ortega
Collaborators: Vicente Bebia Conesa, Silvia Cabrera Diaz, Antonio Gil Moreno, Marta Rebull Santamaria, Ana Luzarraga Aznar, Irene De la Calle Fuentes, Lourdes Elena Salazar Huayna, Melek Denizli
Funding agency: Instituto de Salud Carlos III
Funding: 278300
Reference: DTS23/00091
Duration: 01/01/2024 - 31/12/2026

Desarrollo de un test no invasivo para el diagnóstico de cáncer de endometrio basado en la detección de marcadores proteicos en biopsia líquida cervical

IP: Eva Colas Ortega
Collaborators: Vicente Bebia Conesa, Carina Masferrer Ferragutcasas, Fco Javier De la Torre Fdez de Vega, Silvia Cabrera Diaz, Ana Luzarraga Aznar, Lourdes Elena Salazar Huayna
Funding agency: Instituto de Salud Carlos III
Funding: 177500
Reference: PI23/01470
Duration: 01/01/2024 - 31/12/2026

NUEVAS APROXIMACIONES PARA EL DIAGNÓSTICO DE CÁNCER DE ENDOMETRIO.

IP: Antonio Gil Moreno
Collaborators: Silvia Cabrera Diaz, Marta Rebull Santamaria, Irene De la Calle Fuentes
Funding agency: Ministerio Ciencia, Innovación y Universidades
Funding: 369335
Reference: CPP2021-008440
Duration: 14/02/2022 - 30/09/2025

Ministerio de Ciencia

Related news

The Biomedical Research in Gynaecology group at VHIR has contributed to this international resource with endometrial cancer organoid models.

The ten groups within the Cancer Area combine basic, translational and clinical research to identify new targets, biomarkers and therapeutic strategies

The study evaluated the results of combining SYD985, a HER2 antibody conjugated to a potent cytotoxic drug, and niraparib, an inhibitor of DNA damage repair.

Related professionals

Maria Vidal Burdeus

Maria Vidal Burdeus

Predoctoral researcher
Cardiovascular Diseases
Read more
Maria Eugenia Bustelo Almeida

Maria Eugenia Bustelo Almeida

Research technician
Childhood Cancer and Blood Disorders
Read more
Carolina Gómez Mohen

Carolina Gómez Mohen

Research assistant
Multidisciplinary Nursing Research Group
Read more
Juan Garrido Oliver

Juan Garrido Oliver

Predoctoral researcher
Cardiovascular Diseases
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.